학술행사

Korean Society of Gastrointestinal Cancer Research

학술대회 자료실

제16회 대한소화기암연구학회 춘계학술대회

세종대학교 컨벤션센터 컨벤션홀 2021-06-11

제16회 대한소화기암연구학회 춘계학술대회
컨벤션 A홀 컨벤션 B홀
08:30-09:00 등록
09:00-09:10 인사말 전훈재 이사장님
09:10-10:20 Session I. ASCO/ESMO GI Cancer Symposium 2020 review (What is the NEW?) 좌장: 정현용/방승민 09:10-10:20 Plenary session (Free paper presentation) 좌장: 박선자/박정엽
09:10-09:30 1. Upper GI tract 강선형(충남대) 09:10-09:20 1. Anastomotic leakage and chronic presacral sinus after transanal total mesorectal excision (taTME) for rectal cancer: Comparative study to laparoscopic TME 문성미(가톨릭대)
09:20-09:30 2. A simple scoring model using endoscopic features for selection of colorectal cancer amenable to endoscopic resection 유종욱(연세대)
09:30-09:50 2. Lower GI tract 궁현정(순천향대) 09:30-09:40 3. Comparison of the microbiome diversity in gastric cancer patients and in Non-cancerous patients 방은주(고려대)
09:40-09:50 4. Serial ctDNA monitoring in metastatic pancreatic cancer: A prospective clinical validation study 정광록(서울대)
09:50-10:10 3. Pancreatobiliary tract 전중원(국립암센터) 09:50-10:00 5. Vimentin-positive circulating tumor cells as diagnostic and prognostic biomarkers in biliary tract cancer patients 한성용(부산대)
10:00-10:10 6. Programmed death-ligand 1 expression on tumor infiltrating immune cells is associated with better prognosis in biliary 권성찬(연세대)
10:10-10:20 Q&A 10:10-10:20 7. Optimal adjuvant therapy in patients with borderline resectable and unresectable pancreatic cancer who had received neoadjuvant FOLFIRINOX 최진호(서울대)
10:20-10:40 Coffee break
10:40-12:20 Session II. IASGO joint session : debate for challenging situations in GI malignancy 좌장: 전훈재/박무인 Session II. IASGO joint session: debate or controversial issues of PB malignancy 좌장: 송시영/우상명
10:40-11:00 1. Surgical roles for GE junction cancer: MIS with radicality and multimodality Ming Tsan Lin (National Taiwan University Hospital) 1. Neoadjuvant therapy in resectable and borderline resectable 조인래(서울대)
11:00-11:20 2. Periperatative chemotherapy for locally advaced GE junction cancer 김태호(가톨릭대) 2. Upfront surgery in resectable (R) pancreatic cancer (PC), focusing on clinical benefits of neoadjuvant chemoradiotherapy versus up-front surgery for PC patients Shugo Mizuno (Mie University)
11:20-11:40 3. Radical surgery for rectal cancer after complete remission induced by CRT Soichiro Ishihara (The University of Tokyo Graduate School of Medicine) 3. Neoadjuvant chemotherapy vs. chemoradiotherapy in locally advanced pancreatic cancer: FOLFIRINOX 정문재(연세대)
11:40-12:00 4. Local excision or watch and wait for rectal cancer after CRT (or neoadjuvant therapy) with complete remission 김민정 (서울대) 4. Roles of conversion surgery for unresectable metastatic pancreatic cancer Masayuki Sho (Nara Medical University)
12:20-13:30 Luncheon symposium 좌장: 전훈재
12:20-13:00 The role of gemcitabine in pancreatie cancer 방승민(연세대)
13:00-13:30 총회
13:30-15:00 Session III. From bench to clinic, emerging issues on gastrointestinal cancer 좌장: 최호순/진윤태 13:30-15:00 Session III. Appilcation of AI and big data in gastrointestinal cancers 좌장 : 류지곤/임윤정
13:30-13:50 1. Present and future of Microbiome in GI cancers 박한수(광주과기원) 13:30-13:50 1. Big data analysis with the national health information database 김수영(연세대 원주)
13:50-14:10 2. Application of the organoid in GI cancers 구자록(서울대) 13:50-14:10 2. Cancer research using National Health Insurance big data 박병규(국민건강보험일산병원)
14:10-14:30 3. Circulating tumor DNA as Biomarkers in GI cancer 김동욱(부산대) 14:10-14:30 3. Image analysis with artificial intelligence in gastric cancer 방창석(한림대)
14:30-14:50 4. Single-cell analysis: New armamentarium for translational GI cancer research 이혜옥(카톨릭대) 14:30-14:50 4. How to approach artificial intelligence: Guided by AI expert 김광기(가천대)
14:50-15:00 Q&A 14:50-15:00 Q&A
15:00-15:20 Coffee break
15:20-17:10 Session IV. Immunotherapy and target therapy of gastrointestinal cancers 좌장: 김호각/황진혁 15:20-17:10
16:00-16:50
Free paper session I
Free paper session II
좌장:김현수/이상협
좌장:김병창/한정호
15:20-15:40 1. Introduction of immunotherapy and experience in other malignancy 구동회(성균관대) 15:20-15:28 S-1. Impact of gross tumor morphology on the clinical outcomes of Non-metastatic colon cancer: Multicenter retrospective cohort study 한소정(연세대)
15:28-15:36 S-2. BRCA 1/2 mutation predicts the treatment response of FOLFIRINOX in patients with pancreatic ductal adenocarcinoma 박지훈(연세대)
15:36-15:44 S-3. Prognostic significance of lymph node status in resected ampullary adenocarcinoma followed by adjuvant chemotherapy 박남영(서울대)
15:40-16:00 2. Prospects for immunotherapy and targeted therapy in gastric cancer 문희석(충남대) 15:44-15:52 S-4. M-RNA expression of signet ring cell carcinoma is different from that of poorly cohesive carcinoma in early gastric cancer 강선형(충남대)
15:52-16:00 S-5. Serum biomarker panels for the detection of pancreatic cancer 신동우(서울대)
16:00-16:20 3. Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy 김은선(고려대) 16:00-16:08 S-6. Development of a cachexia-diagnostic model using trajectories of skeletal muscle change 김시영(연세대)
16:08-16:16 S-7. Predicting pulmonary thromboembolism in patients with gastrointestinal cancer using XGBoost machine learning model 김주성(서울대)
16:16-16:24 S-8. A new approaching technique of fluoroscopic-guided biliary biopsy for bile duct stenosis with loop tip guidewire 이강원(고려대)
16:20-16:40 4. Promising immunotherapy and targeted therapy in pancreatobilary cancer 박주경(성균관대) 16:24-16:32 S-9. Effect of fruit and vegetable intake on the risk of esophageal cancer in a large cohort 박정호(경북대)
16:32-16:40 S-10. Long term safety and efficacy of etomidate in comparison with propofol as sedative in gastric neoplasm for endoscopic submucosal dissection 전한조(고려대)
16:40-16:50 Q&A 16:40-16:50 Q&A
16:50-17:10 Best presentation award
17:10- Adjourn